26-A-16334-ACC BEYOND WARFARIN: ARE DIRECT ORAL ANTICOAGULANTS THE FUTURE OF LVAD ANTICOAGULATION? A MULTI-CENTER PROPENSITY-MATCHED ANALYSIS